[PLX] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 15.94%
YoY- -4.89%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 2,686 7,383 1,122 3,359 3,064 3,968 48 1373.81%
PBT -6,119 -7,345 -10,885 -5,747 -6,837 -4,321 968 -
Tax 202 38 0 0 0 0 -1,741 -
NP -6,119 -7,345 -10,885 -5,747 -6,837 -4,321 -9,877 -27.39%
Tax Rate - - - - - - 179.86% -
Total Cost 8,805 14,728 12,007 9,106 9,901 8,289 9,925 -7.69%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin -227.81 -99.49 -970.14 -171.09 -223.14 -108.90 -20,577.08 -95.07%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -0.07 -0.08 -1.18 -0.06 -0.07 -0.05 -1.07 -83.84%
EPS Diluted -0.07 -0.08 -1.17 -0.06 -0.07 -0.05 -1.07 -83.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.